-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Integrated Global Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Public Health and Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety and quality.
COMPLIANCE OVERVIEWIntegrated Global Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
Connected Intelligence
-
AI & Machine Learning
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Genomics
WHO WE ARE
- Our Story
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
AI & Machine Learning with a healthcare IQ.
Artificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Unlock the power of genomic research.
IQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSInstitute Report
Unlocking the Economic Potential of the Health Sector in Latin America
Apr 27, 2018
About the Report
This report provides an in-depth discussion of healthcare sustainability challenges in Latin America, with a focus on Mexico and Colombia. Based on in-depth interviews of past and current government leaders, various win-win policy approaches involving the government and the private sector are explored, along with the ability of each approach to meet identified national healthcare sustainability challenges and support financially sustainable systems in Latin America.
Report Summary
Healthcare spending is often viewed as a necessary burden on government and private spending—something that must be managed carefully and whose growth must be restrained. However, healthcare spending also represents part of a country’s gross domestic product (GDP) and contributes to economic growth like any other sector. One can therefore view healthcare as a strategic sector whose growth and efficiency should be encouraged and where win-win approaches to promote healthcare sustainably through investment and GDP growth can be explored.
While access to healthcare has significantly increased in the last half-century in Latin American countries, these countries still face healthcare sustainability challenges. This report examines various global policy approaches that seek to achieve sustainability by improving efficiency or delivering economic growth and which involve partnerships between government and the private sector. In addition, the report prioritizes a set of approaches based on their likely impact and replicability in Latin America, and further assesses their relevance to meet specific sustainability challenges in Mexico and Colombia—two of the largest Latin American economies—based on in-depth interviews of past and current government leaders in health and finance. These approaches, which offer to increase growth and financial sustainability of the health system, can be used to inform future policies and programs in Colombia and Mexico, and can also be helpful for other countries in the region. Health industry and government officials working to make their countries’ health systems more sustainable and accessible may be able to leverage these approaches to harness the role of the health sector as a potential engine of GDP growth.
Key Findings
Over the past quarter-century, Latin America has made great strides in healthcare coverage
- Argentina, Brazil, Colombia and Mexico have made meaningful progress towards providing universal health coverage (UHC) by increasing access to healthcare services, reducing inequalities and increasing public spending in healthcare.
- Both Colombia and Mexico have established UHC: Colombia in 1993 with Law 100 and a 2015 statutory law that established health as a fundamental right, and Mexico in 2003 with Seguro Popular.
- Governments have made efforts to manage the resultant rise in healthcare use and costs and attain financial sustainability, but some countries remain behind the Organisation for Economic Co-Operation and Development (OECD) average in health expenditure as a percentage of GDP.
Mexico and Colombia face both shared and distinct healthcare challenges
- Both Mexico and Colombia face constrained or reduced healthcare budgets in the face of increasing demand for healthcare services and technologies.
- The two also face a challenge around health expenditure growth. Currently, health expenditure as a percentage of GDP is 6.2% in Colombia and 5.9% in Mexico compared to an OECD average of 9.1%. It is expected that health expenditure as a percentage of GDP will need to grow to at least 8% to meet the demands of the population in Colombia, and to a similar level within Mexico.
- Strategies to achieve sustainable healthcare systems include growing GDP and improving allocative efficiency; both of which can be explored to address challenges in Latin America.
GDP growth strategies offer opportunities for public and private actors to partner, innovate and implement win-win approaches
- Across Mexico and Colombia, the GDP growth approaches – technology transfers and local partnerships within the private sector and innovative contracting and reimbursement models – are perceived to have a high level of economic impact and feasibility/replicability for both countries.
- An allocative efficiency approach, integrated healthcare model, met seven of eight key challenges identified for Mexico and Colombia, and is one of the most widely supported strategies among stakeholders interviewed. Its feasibility/ replicability for Colombia is assessed as high for Colombia but low for Mexico.
- Health industry and government officials working to make their country’s health system more sustainable and accessible may be able to leverage win-win GDP growth approaches to harness the role of the health sector as a potential engine of growth.
- Although public-private cooperation supports sustainability strategies, a troubled past relationship between the pharmaceutical industry and governments will need to be overcome to reach a common goal of a sustainable healthcare system.